STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia. [electronic resource]
Producer: 20020403Description: 207-11 p. digitalISSN:- 1470-2045
- Animals
- Antineoplastic Agents -- pharmacology
- Benzamides
- Clinical Trials, Phase I as Topic
- Disease Models, Animal
- Enzyme Inhibitors -- pharmacology
- Fusion Proteins, bcr-abl -- drug effects
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- diagnosis
- Piperazines -- pharmacology
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- pharmacology
- Sensitivity and Specificity
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.